Vaginal Estrogen Preparations for Relief of Atrophic Vaginitis

American Family Physician

Volumn 69, Issue 9, 2004, Pages 2111-2112

  Nothnagle, Melissa ^a,b   Taylor, Julie Scott ^a  

^a BROWN UNIVERSITY   (United States)

^b MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN;

DRUG EFFICACY; DRUG SAFETY; DYSPAREUNIA; ESTROGEN THERAPY; EVIDENCE BASED MEDICINE; HUMAN; MASTALGIA; MENOPAUSE; NOTE; UTERUS BLEEDING; VAGINA ATROPHY; VAGINAL DRYNESS;

ADMINISTRATION, INTRAVAGINAL; ATROPHY; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; VAGINA;

EID: 2342660143     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (5)

1. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2003:CD001500.
2. Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Matuntas 1992;15:101-111.
3. Molander U, Milsom I, Ekelund P, Mellstrom D. An epidemiological study of urinary incortinence and related urogenital symptoms in elderly women. Maturitas 1990;12:51-60.
4. Willhite LA, O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21:464-80.
5. Pritchard KI. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives. Ann Oncol 2001;12:301-10.